Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're ...

Compounding pharmacy FarmaKeio NM is cementing its role as a crucial part of Winrock Town Center's developing wellness sector. The pharmacy, formerly City Drug, rebranded and relocated to 2100 ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.

A Plano pharmacist billed federal and private payers for hundreds of millions while paying out millions in kickbacks to ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...